Correlation Between Biotechnology Fund and Nationwide Investor

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Biotechnology Fund and Nationwide Investor at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biotechnology Fund and Nationwide Investor into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biotechnology Fund Class and Nationwide Investor Destinations, you can compare the effects of market volatilities on Biotechnology Fund and Nationwide Investor and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biotechnology Fund with a short position of Nationwide Investor. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biotechnology Fund and Nationwide Investor.

Diversification Opportunities for Biotechnology Fund and Nationwide Investor

0.37
  Correlation Coefficient

Weak diversification

The 3 months correlation between BIOTECHNOLOGY and Nationwide is 0.37. Overlapping area represents the amount of risk that can be diversified away by holding Biotechnology Fund Class and Nationwide Investor Destinatio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nationwide Investor and Biotechnology Fund is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biotechnology Fund Class are associated (or correlated) with Nationwide Investor. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nationwide Investor has no effect on the direction of Biotechnology Fund i.e., Biotechnology Fund and Nationwide Investor go up and down completely randomly.

Pair Corralation between Biotechnology Fund and Nationwide Investor

Assuming the 90 days horizon Biotechnology Fund Class is expected to generate 3.69 times more return on investment than Nationwide Investor. However, Biotechnology Fund is 3.69 times more volatile than Nationwide Investor Destinations. It trades about 0.06 of its potential returns per unit of risk. Nationwide Investor Destinations is currently generating about 0.14 per unit of risk. If you would invest  5,020  in Biotechnology Fund Class on September 1, 2024 and sell it today you would earn a total of  363.00  from holding Biotechnology Fund Class or generate 7.23% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy99.21%
ValuesDaily Returns

Biotechnology Fund Class  vs.  Nationwide Investor Destinatio

 Performance 
       Timeline  
Biotechnology Fund Class 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Biotechnology Fund Class has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong technical and fundamental indicators, Biotechnology Fund is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Nationwide Investor 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Nationwide Investor Destinations are ranked lower than 5 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly strong fundamental indicators, Nationwide Investor is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Biotechnology Fund and Nationwide Investor Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Biotechnology Fund and Nationwide Investor

The main advantage of trading using opposite Biotechnology Fund and Nationwide Investor positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biotechnology Fund position performs unexpectedly, Nationwide Investor can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nationwide Investor will offset losses from the drop in Nationwide Investor's long position.
The idea behind Biotechnology Fund Class and Nationwide Investor Destinations pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Other Complementary Tools

Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals